Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer

por Awasthi, Niranjan, Monahan, Sheena, Stefaniak, Alexis, Schwarz, Margaret A., Schwarz, Roderich E.
Publicado 2017